Why Canopy Growth (TSX:WEED) Is the 1 Weed Stock That Won’t Run Out of Business

The Canopy Growth stock is worth watching after the company reported significant progress during its Q3 fiscal 2020. Over the next 90 days, management will be rightsizing the business and building credibility with all stakeholders.

| More on:

The cannabis industry had a turbulent 2019, and the majority of the players were not reporting profits. This year, however, you might see only one genuinely competent and strong participant to operate and not run out of business. Canopy Growth (TSX:WEED)(NYSE:CGC), the sector’s bellwether, is back in the saddle.

But is Canopy Growth sure to turn the corner in 2020? The recent earnings surprise indicates that it was able to stop the bleeding. Now, the company has a crack at finally achieving profitability.

Business growth opportunities of a lifetime

New CEO David Klein kicked off the earnings call last February 14, 2020. His said his reason for joining Canopy Growth was because the cannabis market is one of the most exciting business growth opportunities of our lifetime.

The fiscal 2020 third-quarter results were not spectacular, although the company made significant progress. Canopy’s CFO Mike Lee gave the financial highlights, beginning with the 13% growth in total net revenue. Its business was able to generate 34% gross margins before fair-value impacts.

Canopy had a loss of $92 million, which is better than the $156 million loss in the previous quarter. Canada’s recreational marijuana posted a 10% increase due to balanced growth in the company’s B2B and B2C channels. Medical sales saw a 5% quarter-over-quarter increase, including a 3% increase in international medical.

The strategic acquisitions (Storz & Bickel, This Works, and BioSteel) contributed almost 22% to total revenue. Mr. Lee said Canopy Growth will still be facing some headwinds. Management, however, is designing a supply chain and footprint that applies to the market realities today and well into the next couple of years.

Cash rich

Klein admits the road ahead is not going to be an easy one. His topmost priorities are the following: improve Canopy’s connection with consumers, bring more focus and discipline to the organization, and define a very visible path to profitability and positive cash flow.

Being a subordinate company of Constellation Brands is the advantage of Canopy Growth. The new CEO is assuring investors that the company will not run of cash. Also, the way to win in the market is to possess the most-trusted and most-loved brands.

With an industry that is evolving, Canopy sees the need to focus on specific markets and product lines where the company has the legitimate right to win. Another asset waiting to deliver is the vaunted line of beverage products. Canopy’s weed drinks have yet to finish scaling production. Drinkable products are the next big thing.

Beacon of hope

According to Canopy Growth’s new CEO, there is a lot of work to be done. The company is taking steps to reduce costs and right-size the business to produce a healthy margin profile and generate cash in the years ahead.

Canopy is hoping the days of burning cash and disappointing sales are over. David Klein is confident that Canopy can capitalize on the opportunity to create an unassailable global position in cannabis. Analysts are forecasting the price of $26.40 today could soar by 127.27% to $60 in the next 12 months. Keep your fingers crossed.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »